SEMM Roundtable: Sexual Dimorphism and Beyond in Cancer - Part II

Back to list May 05, 2023

Sexual Dimorphism and Beyond in Cancer - Part II

May 05, 2023 – h. 4.00 p.m.




This is the second of a series of SEMM Rountables aimed at discussing the importance of including sex/gender as a research variable in our projects.
There is strong evidence on the damages produced by the underestimation of gender and sex variables, ranging from low quality research, inefficacy of new drugs, inaccurate or late diagnosis and waste of resources and investments.

These seminars will be of crucial interest to translational/applied research, thus concerning both scientists and clinicians.


Proponents and Chair Persons 



  • Jill S. Barnholtz-Sloan
    Leveraging Big Data for Understanding Sex Differences in Cancer
    CBIIT (Center for Biomedical Informatics and Information Technology), DCEG (Division of Cancer Epidemiology and Genetics), NCI (National Cancer Institute), Bethesda, US
  • Andrew A. Lane
    Cancer Genes on Chromosome X and Y
    Dana-Farber Cancer Institute, Boston, US
  • Berna Oezdemi
    "Cancer Researchers’ Perceptions of the Importance of the Sex of Cell Lines, Animals, and Human Samples for Research"
    Inselspital Bern University Hospita, Medical Oncology, Bern, CH